Regulating the price of prescription drugs in Canada : compulsory licensing, product selection, and government reimbursement programmes / by Paul K. Gorecki. : EC24-11/8-1981E-PDF

"The major findings of the study can be summarized as follows: prices have fallen, often substantially, at the level of the manufacturer for those drugs subject to licensee competition. These price reductions have been passed on to the consumer in the hospital market and, in varying degrees, in the provincial retail drug markets. It is not uncommon for expenditure on a particular licensed drug to be reduced by 50 percent from what it would have been without compulsory licensing and associated policy measures. Nevertheless further gains, often of considerable magnitude, can be achieved in virtually all markets"--Summary, p. xii.

Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.864450&sl=1

• Format MARC XML
• Format MARC HTML

Demander des formats alternatifs